Corbus Pharmaceuticals Holdings, Inc. Equity-NMS: CRBP

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$7.42
Open :$7.46
Today's high :$7.56
Today's low :$7.05
52W low :$4.64
52W high :$61.9
EPS(TTM): :-4.24
Shares O/S :12.24 M
Market cap :89.82 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Corbus Pharmaceuticals Holdings, Inc. $7.34 -0.01% - 89.82M

Frequently Asked Questions

What is the share price of Corbus Pharmaceuticals Holdings, Inc. today?

Corbus Pharmaceuticals Holdings, Inc. (CRBP) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Corbus Pharmaceuticals Holdings, Inc.

Corbus Pharmaceuticals Holdings, Inc. is an oncology and obesity company. The Company has a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The Company’s oncology pipeline comprises two experimental drugs targeting solid tumors: CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, and CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFB expressed on cancer cells. CRB-701 is a monoclonal antibody attached to a monomethyl auristatin E (MMAE) cytotoxic payload using a proprietary linker technology. The pipeline also includes CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. CB1 inverse agonism is a clinically validated mechanism to induce weight loss.